PT-141 (Bremelanotide) is a synthetic peptide derivative of Melanotan II, developed for its selective action on the MC3R and MC4R melanocortin receptors. Unlike other melanocortin analogs that primarily influence pigmentation, PT-141 is studied for its ability to modulate sexual function via central nervous system pathways, independent of nitric oxide mechanisms.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
